Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7074893

Methods and compositions for the treatment of diseases associated with signal transduction

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067109

Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067254

Diagnosis and treatment of inflammation and hyperactive immune conditions

The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052832

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7049066

Diagnosis and treatment of myocardial failure

The Regents of the University of Colorado · Granted Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7045510

Methods for prevention and treatment of mastitis

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7033771

Use of insulin response modulators in the treatment of diabetes and insulin resistance

Takeda Pharmaceutical Company Limited · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7033582

Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorde

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7018986

Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorptio

Immudyne, Inc. · Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7014847

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7012065

Cyclosporins for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7012064

Cyclosporins for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7001884

Eglin c based drugs for treatment of disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6998413

Treatment of neoplasms with yujungamycins

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6998117

Cancer treatment with retroviral vectors comprising wild-type p53

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6995188

S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino)

The Board of Regents of the University of Texas System · Granted Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6992096

1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the tre

PTC THERAPEUTICS, INC. · Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6987166

Compositions and methods for the treatment of sepsis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6984389

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment mo

University of Connecticut Health Center · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6979671

Cyclosporins for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6974568

Treatment for cough

The Regents of the University of California · Granted Tue Dec 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6972124

Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Dec 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6951219

Treatment of hepatitis C using hyperthermia

First Circle Medical, Inc. · Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6946441

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

The Board of Regents of the University of Texas System · Granted Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)